Physician profile
William Su
NPI 1972647212
$578.69
in general payments reported to CMS, 2019-2025
13 companies · $52.54 in 2025
The $52.54 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $15.14 · 2021: $44.40 · 2022: $188 · 2023: $40.20 · 2025: $52.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $125.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $124.16 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Bone Support INC. | $44.40 | 2021 | |
| Heron Therapeutics, INC. | $40.61 | 2022 | |
| Smith+Nephew, INC. | $23.00 | 2022 | |
| Integra Lifesciences Corporation | $20.27 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $19.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Fisher & Paykel Healthcare INC | $19.42 | 2025 | Fisher & Paykel Healthcare |
| Abbott Laboratories | $18.55 | 2025 | Hi-Torque Command |
| Cumberland Pharmaceuticals, INC. | $15.14 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $14.57 | 2025 | |
| Livanova USA, INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.